Ben-Eltriki, Mohamed
Rafiq, Aisha
Paul, Arun
Prabhu, Devashree
Afolabi, Michael O. S.
Baslhaw, Robert
Neilson, Christine J
Driedger, Michelle
Mahmud, Salaheddin M
Lacaze-Masmonteil, Thierry
Marlin, Susan
Offringa, Martin
Butcher, Nancy
Heath, Anna
Kelly, Lauren E
Article History
Received: 2 January 2024
Accepted: 28 June 2024
First Online: 4 October 2024
Declarations
:
: Not applicable
: Not applicable.
: Lauren E Kelly holds funding from the Canadian Institutes of Health Research as the director for the IMPaCT Clinical Trials Training Platform and from Research Manitoba which funded this work. Salaheddin M Mahmud has received unrestricted research grants from GlaxoSmithKline, Merck, Pfizer, Sanofi Pasteur and Roche-Assurex. Salaheddin M Mahmud has received fees as a consultant and advisory board member for GlaxoSmithKline, Merck, Sanofi Pasteur and Seqirus. The remaining authors declare that they have no competing interests.